Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mechanistic target of rapamycin complex 2 (mTORC2) is a large, multi-protein kinase complex that plays a central role in regulating cell proliferation, survival, metabolism, and cytoskeletal organization. It is one of two distinct complexes formed by the mTOR kinase and is characterized by its insensitivity to acute rapamycin treatment. mTORC2 responds primarily to growth factors via PI3K signaling pathways but can also be activated under stress conditions such as nutrient limitation.
mTORC2 is a kinase complex. It phosphorylates Akt/PKB at S473 and S450, which is critical for full Akt activation. It also regulates IGF-I receptor (IGF‑IR), insulin receptor (InsR), and serum/glucocorticoid-induced protein kinase SGK1. It modulates actin cytoskeleton dynamics via F-actin stress fibers formation involving paxillin, RhoA, Rac1, Cdc42, and PKCα.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mechanistic Target Of Rapamycin Complex 2 (mTORC2).